Amphastar Pharmaceuticals Statistics
Total Valuation
AMPH has a market cap or net worth of $1.25 billion. The enterprise value is $1.71 billion.
| Market Cap | 1.25B |
| Enterprise Value | 1.71B |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AMPH has 42.65 million shares outstanding. The number of shares has decreased by -8.01% in one year.
| Current Share Class | 42.65M |
| Shares Outstanding | 42.65M |
| Shares Change (YoY) | -8.01% |
| Shares Change (QoQ) | -1.92% |
| Owned by Insiders (%) | 10.33% |
| Owned by Institutions (%) | 67.24% |
| Float | 31.41M |
Valuation Ratios
The trailing PE ratio is 13.48 and the forward PE ratio is 8.95.
| PE Ratio | 13.48 |
| Forward PE | 8.95 |
| PS Ratio | 1.68 |
| Forward PS | 1.59 |
| PB Ratio | 1.54 |
| P/TBV Ratio | 7.19 |
| P/FCF Ratio | 9.01 |
| P/OCF Ratio | 7.14 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.64, with an EV/FCF ratio of 12.33.
| EV / Earnings | 17.32 |
| EV / Sales | 2.30 |
| EV / EBITDA | 8.64 |
| EV / EBIT | 12.26 |
| EV / FCF | 12.33 |
Financial Position
The company has a current ratio of 3.32, with a Debt / Equity ratio of 0.85.
| Current Ratio | 3.32 |
| Quick Ratio | 2.29 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 3.28 |
| Debt / FCF | 4.98 |
| Interest Coverage | 7.28 |
Financial Efficiency
Return on equity (ROE) is 12.44% and return on invested capital (ROIC) is 8.74%.
| Return on Equity (ROE) | 12.44% |
| Return on Assets (ROA) | 5.17% |
| Return on Invested Capital (ROIC) | 8.74% |
| Return on Capital Employed (ROCE) | 9.13% |
| Weighted Average Cost of Capital (WACC) | 6.82% |
| Revenue Per Employee | $377,423 |
| Profits Per Employee | $50,081 |
| Employee Count | 1,976 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.20 |
Taxes
In the past 12 months, AMPH has paid $30.61 million in taxes.
| Income Tax | 30.61M |
| Effective Tax Rate | 23.63% |
Stock Price Statistics
The stock price has increased by +5.53% in the last 52 weeks. The beta is 0.94, so AMPH's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | +5.53% |
| 50-Day Moving Average | 25.96 |
| 200-Day Moving Average | 22.36 |
| Relative Strength Index (RSI) | 67.21 |
| Average Volume (20 Days) | 466,604 |
Short Selling Information
The latest short interest is 4.26 million, so 9.99% of the outstanding shares have been sold short.
| Short Interest | 4.26M |
| Short Previous Month | 4.33M |
| Short % of Shares Out | 9.99% |
| Short % of Float | 13.57% |
| Short Ratio (days to cover) | 10.25 |
Income Statement
In the last 12 months, AMPH had revenue of $745.79 million and earned $98.96 million in profits. Earnings per share was $2.18.
| Revenue | 745.79M |
| Gross Profit | 349.09M |
| Operating Income | 139.74M |
| Pretax Income | 129.57M |
| Net Income | 98.96M |
| EBITDA | 198.32M |
| EBIT | 139.74M |
| Earnings Per Share (EPS) | $2.18 |
Balance Sheet
The company has $230.63 million in cash and $691.69 million in debt, with a net cash position of -$461.06 million or -$10.81 per share.
| Cash & Cash Equivalents | 230.63M |
| Total Debt | 691.69M |
| Net Cash | -461.06M |
| Net Cash Per Share | -$10.81 |
| Equity (Book Value) | 814.55M |
| Book Value Per Share | 19.10 |
| Working Capital | 421.25M |
Cash Flow
In the last 12 months, operating cash flow was $175.33 million and capital expenditures -$36.31 million, giving a free cash flow of $139.02 million.
| Operating Cash Flow | 175.33M |
| Capital Expenditures | -36.31M |
| Depreciation & Amortization | 58.58M |
| Net Borrowing | -418,000 |
| Free Cash Flow | 139.02M |
| FCF Per Share | $3.26 |
Margins
Gross margin is 46.81%, with operating and profit margins of 18.74% and 13.27%.
| Gross Margin | 46.81% |
| Operating Margin | 18.74% |
| Pretax Margin | 17.37% |
| Profit Margin | 13.27% |
| EBITDA Margin | 26.59% |
| EBIT Margin | 18.74% |
| FCF Margin | 18.64% |
Dividends & Yields
AMPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 8.01% |
| Shareholder Yield | n/a |
| Earnings Yield | 7.42% |
| FCF Yield | 11.10% |
Analyst Forecast
The average price target for AMPH is $24.50, which is -16.58% lower than the current price. The consensus rating is "Hold".
| Price Target | $24.50 |
| Price Target Difference | -16.58% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 4.46% |
| EPS Growth Forecast (3Y) | 1.19% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AMPH has an Altman Z-Score of 2.3 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.3 |
| Piotroski F-Score | 5 |